• Explore /
  • Poster
  • / Assessment of surgical complications in patients with metastatic clear cell renal cell carcinoma (mccRCC) receiving perioperative cabozantinib and nivolumab on Cyto-KIK clinical trial.

Assessment of surgical complications in patients with metastatic clear cell renal cell carcinoma (mccRCC) receiving perioperative cabozantinib and nivolumab on Cyto-KIK clinical trial.

Abstract Poster

Authors

null

Karie Runcie

Columbia University Irving Medical Center, New York, NY

Karie Runcie , Moshe Chaim Ornstein , Biren Saraiya , Venkatesh Krishnamurthi , Byron H Lee , Christopher B. Anderson , Guarionex Joel DeCastro , James M. McKiernan , Matthew Dallos , Tina M. Mayer , Melanie Marron , Alexandria Kulik , Eric A. Singer , Mark N. Stein

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04322955

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 691)

DOI

10.1200/JCO.2023.41.6_suppl.691

Abstract #

691

Poster Bd #

J4

Abstract Disclosures

Similar Posters

First Author: Katy Beckermann

First Author: Thomas Hilser

First Author: Karie Runcie

First Author: Karie Runcie